Healthcare -
Biotechnology - NASDAQ - US
$ 8.02
-0.125 %
$ 178 M
Market Cap
-3.68
P/E
INMB - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity INMB - INmune Bio, Inc.
57 M
LAST VALUE
-24.48%
2 YEAR CAGR
26.84%
5 YEAR CAGR
0.00%
10 YEAR CAGR